These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16725321)

  • 21. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D; McBride JD; Leatherbarrow RJ
    Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.
    Greco MN; Hawkins MJ; Powell ET; Almond HR; de Garavilla L; Hall J; Minor LK; Wang Y; Corcoran TW; Di Cera E; Cantwell AM; Savvides SN; Damiano BP; Maryanoff BE
    J Med Chem; 2007 Apr; 50(8):1727-30. PubMed ID: 17361995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinase.
    Thomas SA; Li T; Woods KW; Song X; Packard G; Fischer JP; Diebold RB; Liu X; Shi Y; Klinghofer V; Johnson EF; Bouska JJ; Olson A; Guan R; Magnone SR; Marsh K; Luo Y; Rosenberg SH; Giranda VL; Li Q
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3740-4. PubMed ID: 16678413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.
    Hua Z; Bregman H; Buchanan JL; Chakka N; Guzman-Perez A; Gunaydin H; Huang X; Gu Y; Berry V; Liu J; Teffera Y; Huang L; Egge B; Emkey R; Mullady EL; Schneider S; Andrews PS; Acquaviva L; Dovey J; Mishra A; Newcomb J; Saffran D; Serafino R; Strathdee CA; Turci SM; Stanton M; Wilson C; Dimauro EF
    J Med Chem; 2013 Dec; 56(24):10003-15. PubMed ID: 24294969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminobenzisoxazoles with biaryl P4 moieties as potent, selective, and orally bioavailable factor Xa inhibitors.
    Quan ML; Han Q; Fevig JM; Lam PY; Bai S; Knabb RM; Luettgen JM; Wong PC; Wexler RR
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1795-8. PubMed ID: 16434195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase.
    Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC
    Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Affinity chromatography of tryptases: design, synthesis and characterization of a novel matrix-bound bivalent inhibitor.
    Schaschke N; Gabrijelcic-Geiger D; Dominik A; Sommerhoff CP
    Chembiochem; 2005 Jan; 6(1):95-103. PubMed ID: 15593113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.
    Hallgren J; Lindahl S; Pejler G
    J Mol Biol; 2005 Jan; 345(1):129-39. PubMed ID: 15567416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
    Maryanoff BE
    J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis, SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCbeta-selective inhibitors.
    Tanaka M; Sagawa S; Hoshi J; Shimoma F; Yasue K; Ubukata M; Ikemoto T; Hase Y; Takahashi M; Sasase T; Ueda N; Matsushita M; Inaba T
    Bioorg Med Chem; 2006 Sep; 14(17):5781-94. PubMed ID: 16762554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-guided design of peptide-based tryptase inhibitors.
    McGrath ME; Sprengeler PA; Hirschbein B; Somoza JR; Lehoux I; Janc JW; Gjerstad E; Graupe M; Estiarte A; Venkataramani C; Liu Y; Yee R; Ho JD; Green MJ; Lee CS; Liu L; Tai V; Spencer J; Sperandio D; Katz BA
    Biochemistry; 2006 May; 45(19):5964-73. PubMed ID: 16681368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
    Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
    J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1).
    Sun D; Wang Z; Cardozo M; Choi R; Degraffenreid M; Di Y; He X; Jaen JC; Labelle M; Liu J; Ma J; Miao S; Sudom A; Tang L; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1522-7. PubMed ID: 19181519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors.
    Jia ZJ; Wu Y; Huang W; Zhang P; Song Y; Woolfrey J; Sinha U; Arfsten AE; Edwards ST; Hutchaleelaha A; Hollennbach SJ; Lambing JL; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1229-34. PubMed ID: 14980671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors.
    Dener JM; Wang VR; Rice KD; Gangloff AR; Kuo EY; Newcomb WS; Putnam D; Wong M
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2325-30. PubMed ID: 11527724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperazine sulfonamides as potent, selective, and orally available 11beta-hydroxysteroid dehydrogenase type 1 inhibitors with efficacy in the rat cortisone-induced hyperinsulinemia model.
    Xiang J; Wan ZK; Li HQ; Ipek M; Binnun E; Nunez J; Chen L; McKew JC; Mansour TS; Xu X; Suri V; Tam M; Xing Y; Li X; Hahm S; Tobin J; Saiah E
    J Med Chem; 2008 Jul; 51(14):4068-71. PubMed ID: 18578516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel benzoxazinones as potent and orally active long chain fatty acid elongase 6 inhibitors.
    Mizutani T; Ishikawa S; Nagase T; Takahashi H; Fujimura T; Sasaki T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
    J Med Chem; 2009 Nov; 52(22):7289-300. PubMed ID: 19883081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer .
    Folkes AJ; Ahmadi K; Alderton WK; Alix S; Baker SJ; Box G; Chuckowree IS; Clarke PA; Depledge P; Eccles SA; Friedman LS; Hayes A; Hancox TC; Kugendradas A; Lensun L; Moore P; Olivero AG; Pang J; Patel S; Pergl-Wilson GH; Raynaud FI; Robson A; Saghir N; Salphati L; Sohal S; Ultsch MH; Valenti M; Wallweber HJ; Wan NC; Wiesmann C; Workman P; Zhyvoloup A; Zvelebil MJ; Shuttleworth SJ
    J Med Chem; 2008 Sep; 51(18):5522-32. PubMed ID: 18754654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinatorial approaches towards the discovery of new tryptase inhibitors.
    del Fresno M; Fernández-Forner D; Miralpeix M; Segarra V; Ryder H; Royo M; Albericio F
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1659-64. PubMed ID: 15745817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.
    Tao ZF; Hasvold LA; Leverson JD; Han EK; Guan R; Johnson EF; Stoll VS; Stewart KD; Stamper G; Soni N; Bouska JJ; Luo Y; Sowin TJ; Lin NH; Giranda VS; Rosenberg SH; Penning TD
    J Med Chem; 2009 Nov; 52(21):6621-36. PubMed ID: 19842661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.